Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 53Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 27Lymphoma, Non-Hodgkin 22Myelodysplastic Syndromes 21Lymphoma, Follicular 21Lymphoma, Mantle-Cell 20Lymphoma, Large B-Cell, Diffuse 20Leukemia, Myeloid, Chronic-Phase 19Lymphoma, Large-Cell, Immunoblastic 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Hodgkin Disease 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Multiple Myeloma 14Leukemia, Myeloid, Accelerated Phase 14Neoplasms, Plasma Cell 10Blast Crisis 10Myeloproliferative Disorders 9Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Anemia, Refractory, with Excess of Blasts 8Waldenstrom Macroglobulinemia 7Recurrence 7

Interventions

Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9fludarabine phosphate 8Whole-Body Irradiation 7Tacrolimus 6Mycophenolic Acid 6Busulfan 6Epoetin Alfa 5Melphalan 4Cyclosporine 4Antilymphocyte Serum 4Methotrexate 3Etoposide 3Darbepoetin alfa 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Morphine 2Methylprednisolone 2Mesna 2Interferon-alpha 2Filgrastim 2Carboplatin 2Bone Marrow Transplantation 2tanespimycin 1sargramostim 1ruxolitinib 1pyroxamide 1peginterferon alfa-2b 1ferrous sulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × sargramostim × Other hematologic neoplasm × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡